Nicotinamide derivates useful as p38 inhibitors

Details for Australian Patent Application No. 2003207298 (hide)

Owner SmithKline Beecham Corporation

Inventors Aston, Nicola Mary; Walker, Ann Louise; Bamborough, Paul

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003207298

PCT Number PCT/GB03/00554

PCT Pub. Number WO2003/068747

Priority 0203301.7 12.02.02 GB; 0225385.4 31.10.02 GB

Filing date 10 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 3 September 2009

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/443 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/04 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 Drugs for skeletal disorders

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 0203301.7 12.02.02 GB; 0225385.4 31.10.02 GB

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003207298

3 September 2009 Application Accepted

  Published as AU-B-2003207298

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207299-5-HT2B RECEPTOR ANTAGONISTS

2003207297-2-oxazolamines and their use as 5-HT2B receptor antagonists